Results 1 -
10
of
32
for
Bortezomib
- Bortezomib is used to treat multiple myeloma (a type of cancer of the bone marrow). Bortezomib is also used to treat mantle cell lymphoma ( ... begins in the cells of the immune system). Bortezomib is in a class of medications called proteasome ...
- Panobinostat is used in combination with bortezomib (Velcade) and dexamethasone to treat people with multiple myeloma (a type of cancer of the bone marrow) who have already been treated ...
- ... 4 other treatments. Selinexor is also used with bortezomib and dexamethasone to treat multiple myeloma in patients ... of each week. For use in combination with bortezomib and dexamethasone for the treatment of multiple myeloma, ...
- ... the immune system) who have been treated with bortezomib (Velcade) and at least one other medication. Lenalidomide ...
- ... lenalidomide (Revlimid) and a proteasome inhibitor such as bortezomib (Velcade) or carfilzomib (Kyprolis). It is also used ...
- Multiple Myeloma: Patient Handbook (International Myeloma Foundation) - PDFMultiple Myeloma/Start Here ... Multiple Myeloma ... International Myeloma Foundation ... PDF
- Treatment of plasma cell neoplasms (including multiple myeloma, monoclonal gammopathy of undetermined significance, and plasmacytoma) includes observation, ...
- General Information about Plasma Cell Neoplasms (Including Multiple Myeloma)
(National Cancer Institute) Multiple Myeloma/Start Here ... Multiple Myeloma ... Amyloidosis/Related Issues ... Amyloidosis ... National Cancer Institute ... Treatment of plasma cell neoplasms (including ... - Multiple Myeloma/Diagnosis and Tests ... Multiple Myeloma ... National Cancer Institute ... From the National Institutes of Health ... Treatment of plasma cell neoplasms ( ...
- A list of cancer drugs approved by the Food and Drug Administration (FDA) for non-Hodgkin lymphoma. The list includes generic names, brand names, and common ...
(National Cancer Institute) 